Outcome
    Moderate Evidence

    Spermidine for Cellular Health

    Cellular benefits are well documented in models but not confirmed by human endpoints.

    Overview

    Cellular benefits are well documented in models but not confirmed by human endpoints.

    Verdict

    Insufficient evidence

    How It Works

    By restoring autophagic flux, spermidine improves mitochondrial quality control and reduces accumulation of damaged proteins.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Studied at 1.2-6 mg/day of spermidine from wheat germ extract; no cellular endpoint has been measured in humans
    Expected timeframe
    Not established

    Protocol

    form
    Wheat germ extract standardised for spermidine content; contains gluten unless certified gluten-free
    duration
    Trials ran 3-12 months
    co factor
    Evidence is insufficient. Spermidine is a polyamine central to cellular function - stabilising nucleic acids, regulating translation through eIF5A hypusination, inducing autophagy and mitophagy, and influencing mitochondrial function - and its decline with age is well documented. Preclinical results are among the more credible in the longevity field, with lifespan extension and cardioprotection in mice. What does not exist is human measurement: no trial has assessed autophagic flux, mitochondrial function, senescent cell burden or any cellular endpoint after spermidine, and cellular health is not a defined or measurable clinical outcome.
    titration
    Not applicable - no dose-response for cellular endpoints exists in humans
    starting dose
    Not established for this outcome. Trials used 1.2-6 mg/day of spermidine from wheat germ extract

    Evidence

    What the studies say

    Preclinical evidence is consistent. Human trials to date report tolerability and modest biomarker shifts, without validated measures of cellular health.

    No studies are yet linked to both Spermidine and Cellular Health.

    Safety

    Caveats

    Cellular health is a marketing frame rather than a measurable state, and the practical consequence is that nobody taking spermidine for it can know whether it is doing anything. Spermidine has better preclinical data than most longevity compounds, but human clinical trials remain small, short and largely negative on their primary endpoints, including a 12-month cognitive trial at 1.2 mg/day. Dietary intake from wheat germ, aged cheese, mushrooms, soy and legumes is where the favourable observational associations come from and is the sensible starting point. Safety of spermidine: up to 6 mg/day appears well tolerated in short trials, with no established upper limit and no long-term safety data in humans. Wheat germ extract contains gluten and is unsuitable in coeliac disease or wheat allergy unless certified gluten-free. Polyamines drive cell proliferation and are elevated in many tumours, so there is theoretical concern about supplementation during active cancer - discuss with an oncology team before use. Safety in pregnancy and breastfeeding is not established. For healthspan, the evidence sits with exercise, not smoking, sleep, limiting alcohol and controlling blood pressure and glucose.

    Less likely to help if

    Everyone - no cellular endpoint is measurable or has been measured.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.